96136-08-2Relevant academic research and scientific papers
UNNATURAL AMINO ACIDS
-
Paragraph 00182; 00203, (2018/07/05)
The present invention relates to a process for the preparation compounds of Formula (I): Formula (I) wherein X, Z, Q, Ar, R1, R2, R3 and R4 are each as defined herein. The present invention also relates to processes for the preparation of the compounds of quaternary amino acids and hydantions, to compound of Formula(I), to intermediate compounds of Formula (II), to quaternary amino acid compounds of Formula (III) and to hydantoin compounds of Formula (IV).
Antifungal amino acid derivative
-
Paragraph 0118; 0121; 0124; 0125, (2018/06/12)
PROBLEM TO BE SOLVED: To provide a new antifungal compound and an amino acid derivative with antifungal properties.SOLUTION: This invention relates to a compound represented by NHR-CHR-C(O)-R(I) or salt thereof, and an antifungal agent including the compound or salt thereof.
Phosphoramidate peptide inhibitors of human skin fibroblast collagenase
Kortylewicz,Galardy
, p. 263 - 273 (2007/10/02)
An extensive series of N-(monoethylphosphoryl)peptides was synthesized and their inhibition of purified human skin fibroblast collagenase examined. At the cleavage site S1 all reported compounds have the (EtO)(OK)P(O) group and the peptide side chain extended toward the C-terminal end (up to P5') of the substrate sequence. These phosphoramidates with a tetrahedrally hybridized phosphorus atom are thought to be transition state analogue inhibitors. They exhibited fair inhibitory potency against this vertebrate collagenase having K(i) values in the micromolar range. The most potent of these, (EtO)(OK)P(O)-Ile-TrpNHCH3 (68), inhibits with a K(i) value of 1.5 μM and is nearly 100 times stronger than (EtO)(OK)P(O)-Ile-Ala-GlyOK (51) (K(i) of 140 μM), which has the sequence matching that of the α1(I) chain of collagen in P1', P2', P3' after the cleavage site. Several compounds were prepared in an attempt to identify the nature of the S2', S3', and S4' binding sites. Alanine at the P2' position was replaced by leucine, phenylalanine, tryptophan, or tyrosine derivatives, resulting in K(i) values in a significantly lower range, 1.0-40 μM, compared to 51. No upper size limitation or specificity has been found at this position, yet similar replacements at the P3' position, which is occupied naturally by a glycine residue, gave weaker inhibitors: (EtO)(OK)P(O)-Ile-Tyr(OBzl)-PheOK (57) had a K(i) of 120 μM. Hexapeptide derivatives had weaker activities in the 270 μM-2 mM range. All inhibitors were evaluated by using the synthetic thio peptolide spectrophotometric assay.
